Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
¿Cuáles son los efectos del tratamiento con azitromicina en pacientes internados por COVID-19?
Introducción:
Un porcentaje considerable de pacientes con infección por coronavirus 2 del síndrome respiratorio agudo grave presentan enfermedad respiratoria que motiva la internación; la enfermedad por coronavirus 2019 puede evolucionar a insuficiencia respiratoria hipoxémica con necesidad de asistencia ventilatoria durante períodos prolongados.
Lectura recomendada:
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a Randomised, Controlled, Open-label, Platform Trial
MedRxiv, :1-31
Lectura recomendada:
Potential of Bacteriophages and their Lysins in the Treatment of MRSA: Current Status and Future Perspectives
Biodrugs, 25(6):347-355
Lectura recomendada:
Emerging Biology of the Cholinergic System across the Spectrum of Alzheimer's Disease
International Psychogeriatrics, 18(Supl. 1):3-16
Lectura recomendada:
Efficacy of New-Generation Antidepressants Assessed With the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale: A Meta-Analysis of Randomised Placebo-Controlled Trials
Plos One, 15(2):1-11
Lectura recomendada:
Dose-Dependent Efficacy of Beta-Blocker in Patients with Chronic Heart Failure and Atrial Fibrillation
International Journal of Cardiology, 273:141-146
Lectura recomendada:
Fampridine Response in MS Patients with Gait Impairment in a Real-World Setting: Need for New Response Criteria?
Multiple Sclerosis, 24(10):1337-1346
Lectura recomendada:
Peginterferon Lambda for the Treatment of Outpatients with COVID-19: a Phase 2, Placebo-controlled Randomised Trial
The Lancet Respiratory Medicine, :1-13
Lectura recomendada:
Predicting Responsiveness to Fampridine in Gait-Impaired Patients with Multiple Sclerosis
European Journal of Neurology, 26(2):281-289
Lectura recomendada:
Antimicrobials and the Risk of Torsades de Pointes: The Contribution From Data Mining of the US FDA Adverse Event Reporting System
Drug Safety, 33(4):303-314
Lectura recomendada:
Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain During 2007
Applied Health Economics and Health Policy, 8(5):301-315
Lectura recomendada:
Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients: A pooled analysis
Respirology, 24:1-8